2010.10.28 Weekly Broadcast Email

The following updates were made to the CCCWFU CCOP Research Base website for the week of October 25, 2010.

DSMB Minutes:
The minutes from the most recent WFU DSMB meeting have been posted on the Adverse Event/DSMB webpage.

97405: (Randomized Study of Soy Protein and Effexor on Vasomotor Symptoms of Men with Prostate Cancer)

The 2010 WFU Continuing Review Approval Letter has been posted to thewebsite.

Reminder: 97509 (A Feasibility Study of Armodafinil for Brain Radiation-Induced Fatigue)

For sites outside of NC, during registration please fax the following items to Cephalon at (610) 883-5566 in order to receive study drug.

  1. DEA License of Patient's Physician
  2. Pharmacy License (if pharmacy will be receiving Armodafinil)
  3. CCOP Shipping Information (Include: name, address, department, etc) 
  4. Curriculum Vitae or Biosketch of Patient's Physician

Announcement: New Study Opens

98110 A Randomized Phase II Dose Finding Study of ArginMax for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated with Radiotherapy

This study offers one cancer control credit and has 140 accruals available. Visit the CCCWFU CCOP Research Base website for the protocol documents.


Quick Reference

Research Base

Phone 336-716-0891
Fax 336-716-6275


2000 West First Street
Protocol Information Office
Suite 101
Winston-Salem, NC 27104
Find A Doctor Ways to Give
Last Updated: 05-11-2015
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.